Melanoma Patient Recruitment in Idaho

TheraNovex connects clinical trial sponsors with pre-screened, eligible Melanoma patients across Idaho, including Boise, Meridian, Nampa, and beyond.

Melanoma clinical trial recruitment for BRAF-mutant, immunotherapy-naive, and advanced stage studies.

Who qualifies: Adults with Stage III–IV melanoma, including BRAF V600E/K mutation-positive patients.

Recruitment challenges: BRAF mutation status and prior immunotherapy exposure eligibility requirements.

Our approach: Dermatology and oncology referral networks, melanoma patient advocacy partnerships.

Our recruitment network spans all major metropolitan areas in Idaho, ensuring broad geographic coverage for your Melanoma trial.